EXAMINE-CAD-DZHK22: First prospective randomized trial to examine a differential therapeutic response in symptomatic patients with non-obstructive coronary artery disease after coronary physiological testing
| Institution | Charité - Universitätsmedizin Berlin |
|---|---|
| Projektleiter | Ulf Landmesser |
| Standort | Berlin |
| Projektart | Klinische Studie |
| Fördersumme | € 868.101,00 |
| Beginn | 15.08.2020 |
| Ende | 31.03.2024 |
Förderkennzeichen
81X1100223
Projektnummer
1220